• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconbiogen

biogen

Page 2 of 4
Workspace-Vaccine Mandate-healthcare shortage
Newsletters
Will vaccine mandates worsen the ongoing health care shortage?
By Yasmin TayagSeptember 30, 2021
The science of a farewell
Newsletters
The science behind a fond farewell
By Sy MukherjeeSeptember 23, 2021
CDC masking indoor businesses Apple
Newsletters
Offices, employees, and customers: The COVID mask conundrum
By Sy MukherjeeJuly 29, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Newsletters
The never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
Health
Biogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By Sy MukherjeeJuly 8, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By Sy MukherjeeJune 7, 2021
FDA Biogen Alzheimer's Janet Woodcock
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021
Drug price hikes big pharma 2021
Health
It’s the New Year, and pharma companies are already hiking prices for popular drugs
By Sy MukherjeeJanuary 4, 2021
OneUnited Bank CEO Kevin Cohee
Finance
Biogen moves $10 million to Black-owned OneUnited, joining the Fortune 500 trend to ‘Bank Black’
By Jen WiecznerSeptember 3, 2020
George Scangos coronavirus czar biotech
Newsletters
Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response
By Sy MukherjeeMarch 2, 2020
Biogen Sangamo Alzheimers gene therapy
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By Sy MukherjeeFebruary 28, 2020
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
Leadership
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
By Susie GharibDecember 6, 2019
Biogen Alzheimers Drug Data
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By Sy MukherjeeDecember 5, 2019
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.